{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-095024","form_type":"8-K","ticker":"ZURA","cik":"0001855644","company_name":"Zura Bio Ltd","filed_at":"2025-09-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.393707+00:00","generated_at":"2026-05-17T05:18:10.030338+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Zura Bio adopts Executive Severance Benefit Plan for CEO and named executives","bullets":["CEO: 12 months base salary on regular termination; 18 months + 150% target bonus on change-in-control termination.","Other named executives: 9 months base salary (regular) or 12 months + 100% target bonus (change-in-control).","Plan effective September 24, 2025; requires signed release agreement for eligibility.","Supersedes any prior severance agreements or arrangements for covered executives."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-095024","json":"https://secwatch.observer/filing/0001104659-25-095024.json","markdown":"https://secwatch.observer/filing/0001104659-25-095024.md","text":"https://secwatch.observer/filing/0001104659-25-095024.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855644/000110465925095024/0001104659-25-095024-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855644/000110465925095024/tm2527486d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:18:10.030338+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}